Please reload

Recent Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

November 26, 2018

Please reload

Featured Posts

Frequency Therapeutics Closes $62MM Series C Financing

July 24, 2019



Congratulations to Frequency Therapeutics!


They have announced the close of their $62mm Series C financing to expand research of their innovative drug candidate for hearing restoration and its potential for other degenerative diseases using their first-in-class Progenitor Cell Activation platform.

Please reload

Follow Us